Prometheus Biosciences Overview

Prometheus Biosciences Operating Income

Operating Income for RXDX.

Quarterly Operating Income

$-48704000.00

↑ 51.74% YoY

As of Mar 31, 2023

Annual Operating Income (TTM)

$-162385000.00

↑ 50.8% YoY

Trailing 12 months ending Mar 31, 2023

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin